Somatropin FDA approval date

The FDA approved Somatropin (Genotropin) on 16 Oct 1986.

FDA approval date
16 Oct 1986

Drug identity checked against registry records

Also recorded as Genotropin

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient ChildrenNCT02968004OPKPhase 3Completed2019-08Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
1986-10-16DaySomatropinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA019640", "applicant_as_listed_by_fda": "LILLY", "brand_names": ["HUMATROPE"], "active_ingredients": ["SOMATROPIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19861016", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026